Literature DB >> 24426826

The impact of gender on timeliness of narcolepsy diagnosis.

Christine Won1, Mandana Mahmoudi2, Li Qin1, Taylor Purvis1, Aditi Mathur1, Vahid Mohsenin1.   

Abstract

STUDY
OBJECTIVES: To examine the impact of gender in narcoleptic patients on timeliness of diagnosis, symptomology, and health and lifestyle impairment.
METHODS: This is a cross-sectional study of 109 consecutive patients (68 women) with newly diagnosed narcolepsy with and without cataplexy, from a University sleep disorders center. Consecutive patients were administered an 8-page questionnaire at the time of their diagnosis regarding sleep habits, medications, and medical conditions, lifestyle impairments, as well as details regarding narcolepsy-related symptoms.
RESULTS: Men and women presented with remarkably similar narcolepsy related symptoms, yet women were more likely to be delayed in diagnosis; 85% of men were likely to be diagnosed by 16 years after symptom onset, compared to 28 years in women. More women were likely to remain undiagnosed at any given time point after symptom onset (hazard ratio for diagnosis of men compared to women 1.53; 95% CI 1.01-2.32; p = 0.04). Men and women reported similar degree of subjective sleepiness as measured by the Epworth Sleepiness Scale (mean 16.2 ± 4.5; p = 0.18), though women demonstrated significantly more severe objective sleepiness on multiple sleep latency testing (MSLT) (mean sleep latency in women = 5.4 min (± 4.1), in men 7.4 min (± 3.5); p = 0.03). Despite being more objectively sleepy, women were less likely to report lifestyle impairments in the areas of personal relationships (71% men, 44% women, p = 0.01) and physical activity (36% men, 16% women, p = 0.02), but were also more likely to self-medicate with caffeine (63.4% men, 82.4% women; p = 0.03).
CONCLUSIONS: Narcolepsy impacts men and women's health and lifestyle differently, and may cause delays diagnosis for women.

Entities:  

Keywords:  Narcolepsy; diagnosis; gender; hypersomnia; sex; sleep; women

Mesh:

Year:  2014        PMID: 24426826      PMCID: PMC3869076          DOI: 10.5664/jcsm.3370

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  51 in total

1.  Increased body-mass index in patients with narcolepsy.

Authors:  A Schuld; J Hebebrand; F Geller; T Pollmächer
Journal:  Lancet       Date:  2000-04-08       Impact factor: 79.321

2.  MAO-A and COMT polymorphisms and gene effects in narcolepsy.

Authors:  Y Dauvilliers; E Neidhart; M Lecendreux; M Billiard; M Tafti
Journal:  Mol Psychiatry       Date:  2001-07       Impact factor: 15.992

3.  Hypocretin (orexin) deficiency in human narcolepsy.

Authors:  S Nishino; B Ripley; S Overeem; G J Lammers; E Mignot
Journal:  Lancet       Date:  2000-01-01       Impact factor: 79.321

4.  Prevalence of sleep-disordered breathing in women: effects of gender.

Authors:  E O Bixler; A N Vgontzas; H M Lin; T Ten Have; J Rein; A Vela-Bueno; A Kales
Journal:  Am J Respir Crit Care Med       Date:  2001-03       Impact factor: 21.405

5.  Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity.

Authors:  J Hara; C T Beuckmann; T Nambu; J T Willie; R M Chemelli; C M Sinton; F Sugiyama; K Yagami; K Goto; M Yanagisawa; T Sakurai
Journal:  Neuron       Date:  2001-05       Impact factor: 17.173

6.  A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains.

Authors:  C Peyron; J Faraco; W Rogers; B Ripley; S Overeem; Y Charnay; S Nevsimalova; M Aldrich; D Reynolds; R Albin; R Li; M Hungs; M Pedrazzoli; M Padigaru; M Kucherlapati; J Fan; R Maki; G J Lammers; C Bouras; R Kucherlapati; S Nishino; E Mignot
Journal:  Nat Med       Date:  2000-09       Impact factor: 53.440

7.  Autoimmune diseases: a leading cause of death among young and middle-aged women in the United States.

Authors:  S J Walsh; L M Rau
Journal:  Am J Public Health       Date:  2000-09       Impact factor: 9.308

8.  Serum leptin and vascular risk factors in obstructive sleep apnea.

Authors:  M S Ip; K S Lam; C Ho; K W Tsang; W Lam
Journal:  Chest       Date:  2000-09       Impact factor: 9.410

Review 9.  Sleep disorders and medical conditions in women. Proceedings of the Women & Sleep Workshop, National Sleep Foundation, Washington, DC, March 5-6, 2007.

Authors:  Barbara A Phillips; Nancy A Collop; Christopher Drake; Flavia Consens; Alexandros N Vgontzas; Terri E Weaver
Journal:  J Womens Health (Larchmt)       Date:  2008-09       Impact factor: 2.681

10.  Reduced number of hypocretin neurons in human narcolepsy.

Authors:  T C Thannickal; R Y Moore; R Nienhuis; L Ramanathan; S Gulyani; M Aldrich; M Cornford; J M Siegel
Journal:  Neuron       Date:  2000-09       Impact factor: 17.173

View more
  9 in total

Review 1.  pitolisant, a novel histamine-3 receptor competitive antagonist, and inverse agonist, in the treatment of excessive daytime sleepiness in adult patients with narcolepsy.

Authors:  Noeen Sarfraz; David Okuampa; Hannah Hansen; Mark Alvarez; Elyse M Cornett; Juyeon Kakazu; Adam M Kaye; Alan D Kaye
Journal:  Health Psychol Res       Date:  2022-05-30

2.  Idling for Decades: A European Study on Risk Factors Associated with the Delay Before a Narcolepsy Diagnosis.

Authors:  Zhongxing Zhang; Yves Dauvilliers; Giuseppe Plazzi; Geert Mayer; Gert Jan Lammers; Joan Santamaria; Markku Partinen; Sebastiaan Overeem; Rafael Del Rio Villegas; Karel Sonka; Rosa Peraita-Adrados; Raphaël Heinzer; Aleksandra Wierzbicka; Birgit Högl; Mauro Manconi; Eva Feketeova; Antonio Martins da Silva; Jitka Bušková; Claudio L A Bassetti; Lucie Barateau; Fabio Pizza; Elena Antelmi; Jari K Gool; Rolf Fronczek; Carles Gaig; Ramin Khatami
Journal:  Nat Sci Sleep       Date:  2022-05-31

3.  Frequencies and Associations of Narcolepsy-Related Symptoms: A Cross-Sectional Study.

Authors:  Lenise Jihe Kim; Fernando Morgadinho Coelho; Camila Hirotsu; Paula Araujo; Lia Bittencourt; Sergio Tufik; Monica Levy Andersen
Journal:  J Clin Sleep Med       Date:  2015-12-15       Impact factor: 4.062

4.  Comorbidities in a community sample of narcolepsy.

Authors:  Alexander Cohen; Jay Mandrekar; Erik K St Louis; Michael H Silber; Suresh Kotagal
Journal:  Sleep Med       Date:  2017-11-21       Impact factor: 3.492

5.  Data-Driven Phenotyping of Central Disorders of Hypersomnolence With Unsupervised Clustering.

Authors:  Jari K Gool; Zhongxing Zhang; Martijn S S L Oei; Stephanie Mathias; Yves Dauvilliers; Geert Mayer; Giuseppe Plazzi; Rafael Del Rio-Villegas; Joan Santamaria Cano; Karel Šonka; Markku Partinen; Sebastiaan Overeem; Rosa Peraita-Adrados; Raphael Heinzer; Antonio Martins da Silva; Birgit Högl; Aleksandra Wierzbicka; Anna Heidbreder; Eva Feketeova; Mauro Manconi; Jitka Bušková; Francesca Canellas; Claudio L Bassetti; Lucie Barateau; Fabio Pizza; Markus H Schmidt; Rolf Fronczek; Ramin Khatami; Gert Jan Lammers
Journal:  Neurology       Date:  2022-04-18       Impact factor: 11.800

6.  Narcolepsy - Between the dream and reality.

Authors:  Fernando Morgadinho Santos Coelho
Journal:  Sleep Sci       Date:  2014-08-19

7.  Central Disorders of Hypersomnolence in Children and Adults: A Comparative Study from South India.

Authors:  Madhukar Trivedi; Sapna Erat Sreedharan; Shana N Nair; C A Anees; J P Unnikrishnan; P S Sarma; Ashalatha Radhakrishnan
Journal:  Ann Indian Acad Neurol       Date:  2019-10-25       Impact factor: 1.383

Review 8.  Narcolepsy Presentation in Diverse Populations: an Update.

Authors:  Karen Spruyt
Journal:  Curr Sleep Med Rep       Date:  2020-11-25

Review 9.  Role of Brown Adipose Tissue in Adiposity Associated With Narcolepsy Type 1.

Authors:  Maaike E Straat; Mink S Schinkelshoek; Rolf Fronczek; Gerrit Jan Lammers; Patrick C N Rensen; Mariëtte R Boon
Journal:  Front Endocrinol (Lausanne)       Date:  2020-04-16       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.